The relationship between serum lumican levels and myocardial fibrosis in patients with hypertrophic cardiomyopathy

被引:0
|
作者
Hancioglu, E. [1 ]
Ozcan, S. [1 ]
Donmez, E. [1 ]
Okuyan, E. [1 ]
Sahin, I [1 ]
机构
[1] Istanbul Bagcilar Training & Res Hosp, Istanbul, Turkiye
关键词
D O I
10.1093/eurheartj/ehae666.2012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [21] SANDOSTATIN DECREASES MYOCARDIAL FIBROSIS IN HYPERTROPHIC CARDIOMYOPATHY
    TARABEN, A
    CAMPBELL, SE
    JONES, J
    KOPPLIN, D
    KHARDORI, R
    CIRCULATION, 1995, 92 (08) : 2521 - 2521
  • [22] Genetic regulation of myocardial fibrosis in hypertrophic cardiomyopathy
    Patel, V.
    Syrris, P.
    Coats, C.
    Lucena, J.
    Lara-Pezzi, E.
    Garcia-Pavia, P.
    Elliott, P. M.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1778 - 1778
  • [23] Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy
    Ho, Carolyn Y.
    Lopez, Begona
    Coelho-Filho, Otavio R.
    Lakdawala, Neal K.
    Cirino, Allison L.
    Jarolim, Petr
    Kwong, Raymond
    Gonzalez, Arantxa
    Colan, Steven D.
    Seidman, J. G.
    Diez, Javier
    Seidman, Christine E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (06): : 552 - 563
  • [24] Prognostic Significance of Myocardial Fibrosis in Hypertrophic Cardiomyopathy
    O'Hanlon, Rory
    Grasso, Agata
    Roughton, Michael
    Moon, James C.
    Clark, Susan
    Wage, Ricardo
    Webb, Jessica
    Kulkarni, Meghana
    Dawson, Dana
    Sulaibeekh, Leena
    Chandrasekaran, Badri
    Bucciarelli-Ducci, Chiara
    Pasquale, Ferdinando
    Cowie, Martin R.
    McKenna, William J.
    Sheppard, Mary N.
    Elliott, Perry M.
    Pennell, Dudley J.
    Prasad, Sanjay K.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (11) : 867 - 874
  • [25] Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy
    Hanlon, R. O'
    Grasso, A.
    Roughton, M.
    Moon, J. C.
    Wage, W.
    Bucciarelli-Ducci, C.
    Mckenna, W. J.
    Elliott, P. M.
    Pennell, D. J.
    Prasad, S. K.
    EUROPEAN HEART JOURNAL, 2010, 31 : 331 - 331
  • [26] Myocardial Fibrosis in Patients with Hypertrophic Cardiomyopathy and High Risk for Sudden Death
    Shiozaki, Afonso Akio
    Senra, Tiago
    Arteaga, Edmundo
    Pita, Cristiane Guedes
    Martinelli Filho, Martino
    Avila, Luis Francisco R.
    Parga Filho, Jose Rodrigues
    Mady, Charles
    Rochitte, Carlos Eduardo
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2010, 94 (04) : 535 - 540
  • [27] Detection of myocardial fibrosis in patients with hypertrophic cardiomyopathy evaluated by biological markers
    Zaroui, A.
    Asmi, M.
    Tejelbenet, C.
    Ben Said, R.
    Kaabachi, N.
    Mourali, M. S.
    Mechmeche, R.
    EUROPEAN HEART JOURNAL, 2015, 36 : 146 - 146
  • [28] Systemic inflammation is associated with myocardial fibrosis in patients with obstructive hypertrophic cardiomyopathy
    Guo, Xinli
    Zhang, Jian
    Huang, Manyun
    Song, Changpeng
    Nie, Changrong
    Zheng, Xinxin
    Wang, Shuiyun
    Huang, Xiaohong
    ESC HEART FAILURE, 2025, 12 (01): : 582 - 591
  • [29] Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy
    Fang, L.
    Ellims, A.
    Moore, X. -L.
    White, D.
    Taylor, A.
    Chin-Dusting, J.
    Dart, A.
    EUROPEAN HEART JOURNAL, 2015, 36 : 452 - 452
  • [30] Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy
    Lu Fang
    Andris H. Ellims
    Xiao-lei Moore
    David A. White
    Andrew J. Taylor
    Jaye Chin-Dusting
    Anthony M. Dart
    Journal of Translational Medicine, 13